{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:55:18Z","timestamp":1763535318596,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ando.2015.03.009","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T08:50:28Z","timestamp":1428915028000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypoparathyroidism\u00a0\u2013\u00a0disease update and emerging treatments"],"prefix":"10.1016","volume":"76","author":[{"given":"Elizabeth L.","family":"Monis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.03.009_bib0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0235","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0240","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0245","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1245\/s10434-014-3846-8","article-title":"Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons","volume":"21","author":"Hauch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2015.03.009_bib0250","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"year":"2006","series-title":"Genetic disorders of calcium homeostasis caused by abnormal regulation of parathyroid hormone secretion or responsiveness","author":"Thakker","key":"10.1016\/j.ando.2015.03.009_bib0255"},{"key":"10.1016\/j.ando.2015.03.009_bib0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ceca.2003.10.010","article-title":"Diseases associated with the extracellular calcium-sensing receptor","volume":"35","author":"Thakker","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ando.2015.03.009_bib0265","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0270","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting Galpha11 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0275","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2003-031943","article-title":"GCMB\u00a0\u2013\u00a0another serendipitous gift from evolution to clinical investigators","volume":"89","author":"Kronenberg","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/JOE-10-0247","article-title":"Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism","volume":"210","author":"Mannstadt","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.009_bib0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2011.06221.x","article-title":"Transcription factors in parathyroid development: lessons from hypoparathyroid disorders","volume":"1237","author":"Grigorieva","year":"2011","journal-title":"Ann N Y Acad Sci"},{"year":"2015","series-title":"Parathyroid hormone gene. structure, evoluation, and regulation. The parathyroids","author":"Mannstadt","key":"10.1016\/j.ando.2015.03.009_bib0295"},{"key":"10.1016\/j.ando.2015.03.009_bib0300","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","article-title":"Velocardiofacial syndrome. DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes","volume":"370","author":"Kobrynski","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2015.03.009_bib0305","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(00)04254-9","article-title":"Genetic developments in hypoparathyroidism","volume":"357","author":"Thakker","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2015.03.009_bib0310","doi-asserted-by":"crossref","first-page":"22624","DOI":"10.1074\/jbc.M401797200","article-title":"Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome","volume":"279","author":"Nesbit","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ando.2015.03.009_bib0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng1012","article-title":"Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome","volume":"32","author":"Parvari","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2015.03.009_bib0320","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM196606022742203","article-title":"Effect of diphenylhydantoin and phenobarbital on overt and latent tetany","volume":"274","author":"Schaaf","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9610(58)90868-7","article-title":"The Chvostek sign; a clinical study","volume":"96","author":"Hoffman","year":"1958","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2015.03.009_bib0330","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archinte.1967.00300020074009","article-title":"Neurological manifestations of hypoparathyroidism","volume":"120","author":"Fonseca","year":"1967","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001980200009","article-title":"Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone","volume":"13","author":"Minisola","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.03.009_bib0340","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0345","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0350","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u00a0\u2013\u00a0risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0355","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0002-9343(89)90338-0","article-title":"Normal left ventricular performance documented by Doppler echocardiography in patients with long-standing hypocalcemia","volume":"86","author":"Vered","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.03.009_bib0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.009_bib0365","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0030-4220(81)90061-X","article-title":"Calcific bridging of dental pulp caused by iatrogenic hypercalcemia. Report of a case","volume":"51","author":"Nikiforuk","year":"1981","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.ando.2015.03.009_bib0370","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The Effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0375","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4158\/EP13328.OR","article-title":"Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study","volume":"20","author":"Hadker","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2015.03.009_bib0380","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.009_bib0385","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0390","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0395","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0400","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2015.03.009_bib0405","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0410","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0415","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0420","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","article-title":"PTH (1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects following 6 months of treatment","volume":"28","author":"Sikjaer","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0425","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0455","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.03.009_bib0435","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.009_bib0440","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.03.009_bib0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.009_bib0450","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342661500030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342661500030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:54Z","timestamp":1757717334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342661500030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S000342661500030X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.009","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoparathyroidism\u00a0\u2013\u00a0disease update and emerging treatments","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}